Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
Study First Submitted
Endpoints
Primary
Percentage of Participants With an Increase of at Least 1 Point in Cerebral Perfusion Staging Score
Timeframe: Baseline (before intervention) and the day after completion of the 3-month treatment course
Secondary (7)
Fugl-Meyer Assessment of Motor Function Score
Modified Barthel Index Score
Montreal Cognitive Assessment Score
National Institutes of Health Stroke Scale Score
Incidence of New Intracerebral Hemorrhage
Show 2 moreShow less
Incidence of Recurrent or New Cerebral Infarction
All-Cause Mortality
Arms and interventions
Atorvastatin + Replenishing Five Herbs DecoctionExperimental
Treatment with "Replenishing Five Herbs Decoction" (200ml per dose, twice daily, one dose per application, as per internal protocol of Nanjing Central Hospital), supplemented with Atorvastatin (produced by Pfizer, USA, national drug registration number H20051407, 10mg, one tablet daily).
Atorvastatin + Replenishing Five Herbs Decoction PlaceboPlacebo comparator
The treatment consists of a placebo pill, combined with atorvastatin (produced by Pfizer, registration number H20051407, 10mg, taken once daily, one tablet). The placebo is a mixture of 10% herbal extract and rice, combined with edible seasonings, and has the same appearance, shape, smell, and specifications as the "Yang Huo Han Wu" formula.
Drugs: Atorvastatin, Replenishing Five Herbs Decoction, Replenishing Five Herbs Decoction Placebo
Sites
1 site in 1 country
Jiangsu Province Hospital (Jiangsu Provincial People's Hospital)Nanjing, Jiangsu, China